Previous studies have demonstrated how the epigenetic process of DNA methylation is involved in response to psychological therapies, particularly the methylation of FKBP5 at its promoter region, which is associated with PTSD and anti-depressant therapy responses (135, 164). This evidence concerns the gene FKBP5 and post-traumatic stress disorder.